Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids Effects on Aspirin Resistance
NCT00771914Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Nov 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of eicosapentaenoic acid + docosahexaenoic acid (4 arms), sponsored by University of Rochester. Primary endpoint: Difference Between the Time to Clot Formation in Seconds at Baseline and After Each Treatment at 4 hours. Started Nov 2008; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
Beyond the preview
Go deeper on NCT00771914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771914.